» Articles » PMID: 28706114

One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden From 1998 to 2010: An Observational Study

Overview
Journal Stroke
Date 2017 Jul 15
PMID 28706114
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Recent data on the incidence, time trends, and predictors of recurrent ischemic stroke are limited for unselected patient populations.

Methods: Data for ischemic stroke patients were obtained from The Swedish Stroke Register (Riksstroke) between 1998 and 2009 and merged with The Swedish National Inpatient Register. A reference group of patients was created by Statistics Sweden. The ischemic stroke patient cohort was divided into 4 time periods. Recurrent ischemic stroke within 1 year was recorded until 2010. Kaplan-Meier and Cox regression analyses were performed to study time trends and predictors of ischemic stroke recurrence.

Results: Of 196 765 patients with ischemic stroke, 11.3% had a recurrent ischemic stroke within 1 year. The Kaplan-Meier estimates of the 1-year cumulative incidence of recurrent ischemic stroke decreased from 15.0% in 1998 to 2001 to 12.0% in 2007 to 2010 in the stroke patient cohort while the cumulative incidence of ischemic stroke decreased from 0.7% to 0.4% in the reference population. Age >75 years, prior ischemic stroke or myocardial infarction, atrial fibrillation without warfarin treatment, diabetes mellitus, and treatment with β-blockers or diuretics were associated with a higher risk while warfarin treatment for atrial fibrillation, lipid-lowering medication, and antithrombotic treatment (acetylsalicylic acid, dipyridamole) were associated with a reduced risk of recurrent ischemic stroke.

Conclusions: The risk of recurrent ischemic stroke decreased from 1998 to 2010. Well-known risk factors for stroke were associated with a higher risk of ischemic stroke recurrence; whereas, secondary preventive medication was associated with a reduced risk, emphasizing the importance of secondary preventive treatment.

Citing Articles

Recurrent Ischemic Stroke and Transient Ischemic Attack: Risk of Single and Multiple Recurrence.

Park M, Lee S, Jung J J Clin Med. 2024; 13(19).

PMID: 39407804 PMC: 11477265. DOI: 10.3390/jcm13195744.


High-Sensitivity Cardiac Troponin T and Cardiovascular Risk After Ischemic Stroke or Transient Ischemic Attack.

Willeit K, Boehme C, Toell T, Tschiderer L, Seekircher L, Mayer-Suess L JACC Adv. 2024; 3(7):101022.

PMID: 39130023 PMC: 11312770. DOI: 10.1016/j.jacadv.2024.101022.


Investigation of vascular risk factor control and secondary prevention medication compliance in acute ischemic stroke.

Chen Y, Zhang Y, Jiang L, Lu Y, Ding X, Jin W Front Neurol. 2024; 15:1365860.

PMID: 38974682 PMC: 11224152. DOI: 10.3389/fneur.2024.1365860.


Patient Readmission for Ischemic Stroke: Risk Factors and Impact on Mortality.

Liu C, Luo L, He X, Wang T, Liu X, Liu Y Inquiry. 2024; 61:469580241241271.

PMID: 38529892 PMC: 10966977. DOI: 10.1177/00469580241241271.


Exploring the Multifaceted Causes of Ischemic Stroke: A Narrative Review.

Gupta C, Wagh V Cureus. 2023; 15(10):e47531.

PMID: 38021859 PMC: 10664821. DOI: 10.7759/cureus.47531.